HKSE:08158 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:08158 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
China Regenerative Medicine International's Dividends per Share for the three months ended in Jun. 2024 was HK$0.00.
The historical rank and industry rank for China Regenerative Medicine International's 3-Year Dividend Growth Rate or its related term are showing as below:
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
China Regenerative Medicine International's Dividend Payout Ratio for the three months ended in Jun. 2024 was 0.00. As of today, China Regenerative Medicine International's Dividend Yield % is 0.00%.
For more information regarding to dividend, please check our Dividend Page.
For the Biotechnology subindustry, China Regenerative Medicine International's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where China Regenerative Medicine International's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
China Regenerative Medicine International (HKSE:08158) 3-Year Dividend Growth Rate Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
China Regenerative Medicine International's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Jun. 2024 ) | / | EPS without NRI (Q: Jun. 2024 ) |
= | 0 | / | 0 | |
= | N/A |
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wang Chuang | 2101 Beneficial owner | |
Wong Kwok Keung | 2501 Other | |
Arab Osman Mohammed | 2501 Other | |
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo | 2201 Interest of corporation controlled by you | |
Lei Changjuan | 2101 Beneficial owner | |
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo | 2201 Interest of corporation controlled by you | |
Kong Yudong | 2101 Beneficial owner | |
Li Ren | 2201 Interest of corporation controlled by you | |
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited) | 2201 Interest of corporation controlled by you | |
All Favour Holdings Limited | 2101 Beneficial owner | |
Deng Shufen | 2202 Interest of your spouse | |
Dai Yumin | 2201 Interest of corporation controlled by you | |
Wang Xiaogang | 2101 Beneficial owner | |
China Orient Asset Management Co., Ltd. | 2106 Person having a security interest in shares | |
China Orient Alternative Investment Fund | 2106 Person having a security interest in shares |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.